ስለ Dendreon Corporation

Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein. Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge. Source: Wikipedia
ዋና መሥሪያ ቤትCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
የተመሠረተ2013
ሁኔታንቁ

ፓተንቶች134 ፓተንቶች

HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH…CA2923433C · 2020
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with…US10261091B2 · 2019
ሁሉንም 134 ፓተንቶች ለማየት ይግቡ

ሙሉውን የፓተንት ፖርትፎሊዮ ከሕትመት ቁጥሮች፣ ቀናት እና ቤተሰቦች ጋር ያስሱ።

ይግቡ በኢሜይልዎ መለያ ይፍጠሩ

ነፃ ነው

በHeelky ላይ ሁሉንም ፓተንቶች ፈልግ →

ግምገማዎች

እስካሁን ግምገማ የለም። ከDendreon Corporation ጋር ሠርተዋል? ልምድዎን የሚያጋሩ የመጀመሪያው ይሁኑ።

ግምገማ ይጻፉ →

እውቂያ & አገናኞች

ቦታ

Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US

ይህ ኩባንያዎ ነው?

አርማዎን፣ ምርቶችዎን፣ ፎቶዎችዎን እና ሥራዎችዎን ለመጨመር እና ግምገማዎችን ለመመለስ ይህን ገጽ በነፃ ይውሰዱ።

ይህን ገጽ ይውሰዱ

ይህን ኩባንያ ያጋሩ

Dendreon CorporationCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, UShttps://heelky.com/explore/companies/dendreon-corporation-q9lqmwsf/

አገናኝ ቅዳ

ያጋሩ በ

QR ኮድ

ይህን ገጽ ለመክፈት በስልክ ካሜራ ይቃኙት፣ ወይም ለበራሪ ወረቀት፣ ለስላይድ ወይም ለባጅ ያውርዱት።

ለመገናኘት፣ ለመቅጠር እና ለማደግ Heelkyን ይቀላቀሉ

ለሰዎች መልዕክት ለመላክ፣ ለሥራ ለማመልከት እና ተልዕኮዎችን ለመለጠፍ ነፃ መለያ ይፍጠሩ።

አሁን ይቀላቀሉ — ነፃ ነው

ቋንቋዎን ይምረጡ

Heelky ምርጫዎን ያስታውሳል።

ሌሎች ቋንቋዎች

የሚገኙ ቋንቋዎች፦ 70 በ Heelky ላይ ስለ ቋንቋዎች